Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 172–172 | Cite as

Erlotinib

Rash, skin dryness and very mild skin peeling: case report
Case report
  • 18 Downloads

Reference

  1. Swami U, et al. Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion. Journal of Thoracic Oncology 13: e129-e130, No. 7, Jul 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.03.034 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations